JP2023523096A5 - - Google Patents
Info
- Publication number
- JP2023523096A5 JP2023523096A5 JP2023506362A JP2023506362A JP2023523096A5 JP 2023523096 A5 JP2023523096 A5 JP 2023523096A5 JP 2023506362 A JP2023506362 A JP 2023506362A JP 2023506362 A JP2023506362 A JP 2023506362A JP 2023523096 A5 JP2023523096 A5 JP 2023523096A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- approximately
- acid sequence
- sequence seq
- containing amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063012786P | 2020-04-20 | 2020-04-20 | |
| US202063012783P | 2020-04-20 | 2020-04-20 | |
| US63/012,783 | 2020-04-20 | ||
| US63/012,786 | 2020-04-20 | ||
| US202063081662P | 2020-09-22 | 2020-09-22 | |
| US63/081,662 | 2020-09-22 | ||
| PCT/CA2021/050544 WO2021212222A1 (en) | 2020-04-20 | 2021-04-20 | Compositions and methods for treatment of acute respiratory distress syndrome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023523096A JP2023523096A (ja) | 2023-06-01 |
| JP2023523096A5 true JP2023523096A5 (https=) | 2024-04-25 |
Family
ID=78270861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023506362A Pending JP2023523096A (ja) | 2020-04-20 | 2021-04-20 | 急性呼吸促迫症候群を治療するための組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230192881A1 (https=) |
| EP (1) | EP4138912A4 (https=) |
| JP (1) | JP2023523096A (https=) |
| CN (1) | CN115697410A (https=) |
| AU (1) | AU2021261060A1 (https=) |
| CA (1) | CA3174429A1 (https=) |
| IL (1) | IL297363A (https=) |
| WO (1) | WO2021212222A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020149518A1 (ko) * | 2019-01-14 | 2020-07-23 | 주식회사 에이아이인사이트 | 안저영상 자동판독을 위한 딥러닝 아키텍처 시스템 및 딥러닝 아키텍쳐 시스템을 이용한 안저영상 자동판독 방법 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7674884B2 (en) * | 2003-12-10 | 2010-03-09 | Novimmune S.A. | Neutralizing antibodies and methods of use thereof |
| US7312320B2 (en) * | 2003-12-10 | 2007-12-25 | Novimmune Sa | Neutralizing antibodies and methods of use thereof |
| JP2010526868A (ja) * | 2007-05-14 | 2010-08-05 | ノビミューン エスアー | 改変されたエフェクター機能を有するＦｃ受容体結合ポリペプチド |
| US8734790B2 (en) * | 2011-01-10 | 2014-05-27 | Novimmune Sa | Anti-TLR4 antibodies and methods of use thereof |
| HUE037613T2 (hu) * | 2012-03-29 | 2018-09-28 | Novimmune Sa | Anti-TLR4 antitestek és azok felhasználása |
| WO2015059168A1 (en) * | 2013-10-22 | 2015-04-30 | Novimmune S.A. | Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of tlr4 ligands and other biomarkers |
| US20170038381A1 (en) * | 2015-08-06 | 2017-02-09 | Novimmune Sa | Methods and compositions for identifying patient populations for diagnosis and treatment of tlr4-dependent disorders |
| CA3037961A1 (en) * | 2016-09-30 | 2018-04-05 | Janssen Biotech, Inc. | Safe and effective method of treating psoriasis with anti-il23 specific antibody |
-
2021
- 2021-04-20 CA CA3174429A patent/CA3174429A1/en active Pending
- 2021-04-20 US US17/920,323 patent/US20230192881A1/en active Pending
- 2021-04-20 IL IL297363A patent/IL297363A/en unknown
- 2021-04-20 CN CN202180043755.8A patent/CN115697410A/zh active Pending
- 2021-04-20 AU AU2021261060A patent/AU2021261060A1/en active Pending
- 2021-04-20 WO PCT/CA2021/050544 patent/WO2021212222A1/en not_active Ceased
- 2021-04-20 JP JP2023506362A patent/JP2023523096A/ja active Pending
- 2021-04-20 EP EP21791947.1A patent/EP4138912A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023515271A5 (https=) | ||
| JP2020518599A5 (https=) | ||
| JP2023538369A5 (https=) | ||
| JP2004534513A5 (https=) | ||
| JP2024518536A5 (https=) | ||
| JP2023523096A5 (https=) | ||
| JP2022535523A5 (https=) | ||
| JP2025176030A (ja) | ウイルス起源の各感染症の治療のためのペプチド | |
| JP2024177399A (ja) | 呼吸器疾患の治療のための汎ｅｌｒ＋ｃｘｃケモカイン抗体 | |
| JP2022531205A5 (https=) | ||
| US20240117058A1 (en) | Treatment of cytokine release syndrome with gm-csf antagonists | |
| EP4655001A1 (en) | Method for prevention or treatment of coronavirus infection | |
| US20230357418A1 (en) | Results of empacta: a randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of tocilizumab in hospitalized patients with covid-19 pneumonia | |
| JP2023526853A5 (https=) | ||
| JP2023518812A (ja) | Ｃｏｖｉｄ１９肺炎を治療するための、トシリズマブとレムデシビルとの組み合わせ | |
| WO2021181279A1 (en) | Compositions and methods for treating covid-19 infections and/or symptoms thereof | |
| CN121240885A (zh) | 预防或治疗冠状病毒感染的方法 | |
| KR20250148609A (ko) | 코로나바이러스 감염의 예방 또는 치료 방법 | |
| KR20250148604A (ko) | 코로나바이러스 감염의 예방 또는 치료 방법 | |
| JP2025511167A5 (https=) | ||
| WO2024158285A1 (en) | Method for prevention or treatment of coronavirus infection |